Gastroenteritis in the pediatric population is a very common disease that could be lethal. It accounts for around 10% of pediatric deaths, estimating 70 million deaths per year around the globe making it the second cause of death worldwide. The most common cause in infants younger than 24 months old is rotavirus, after 24 months of age, Shigella displaces it to second most common.
Gastroenteritis occurs when there is a fecal-oral contact, ingestion of contaminated water or food and person to person, been this the most common way of acquiring this infection and making it the main cause for norovirus and shigella outbreaks. This disease is associated with bad hygiene and poverty.
In the United States, rotavirus and noroviruses (accountable for almost 58% of all cases) are the most common viral agent that causes diarrhea, followed by enteric adenoviruses, Sapovirus, and astroviruses.
The main risk factors for gastroenteritis are environmental, seasonal, and demographics, being you children more susceptible. Other diseases like measles and immunodeficiencies put the patient at a higher risk for a gastrointestinal (GI) infection. Malnutrition is another significant risk factor, like vitamin-A deficiency or zinc deficiency.
Most of the episodes are acute diarrheas, lasting less than one week. When diarrhea lasts more than 14 days, it is considered persistent diarrhea and accounts for 3% to 19% of episodes. Around 50% of death cases due to diarrhea.
Children under 5 years of age are the most affected population, and the diarrheal episodes happen more frequently in Asia and Africa, accounting for 80% of annual incidence.
The pathophysiology depends on the organism causing the disease. It can caused by toxins like Staphylococcus aureus, while others increase secretion leading to dehydration, for example, Salmonella. Cytotoxins like Shigella and Clostridium difficile can invade the more susceptible tissue and cause inflammatory diarrhea. Enterotoxin production agents cause noninflammatory diarrhea; the virus frequently destroys the villus surface, and parasites adhere to the mucosa.
In the case of inflammatory diarrhea, there are fluid, proteins, and leukocytes entering the interstitial lumen. Viruses like adenovirus can directly invade the microvillus or through calcium-dependent endocytosis, causing the loss in the ability to absorb.
On a molecular level, agents affect the interstitial lumen by activating enterocyte intracellular signal transduction, affecting the cytoskeleton of the host cells. This will alter the water and electrolyte fluxes across the enterocytes. For toxic diarrhea, there is an increase of cAMP and inhibition of NaCl abortion. When infiltration occurs, there is histologic damage that will reduce glucose, stimulated Na, and electroneutral NaCl absorption.
The clinical manifestations will be related to the pathogen. Ingestion of toxins (S. aureus) can lead to rapid onset of nausea and vomiting within 6 hours of digestion. Patients may have fever, cramps, and diarrhea within 8 to 72 hours.
Enterotoxins like Clostridium perfringens and Bacillus cereus cause watery diarrhea within 8 to 16 hours of ingestion. Viral infections are associated with cramps and watery diarrhea after 16 to 48 hours. There are some pathogens that are related to bloody diarrhea. These agents can cause symptoms up to 120 hours after ingestion. Some agents can cause manifestations within minutes, for example, copper, shellfish toxins, tin, and other seafood (puffer fish) through tetrodotoxin or scombroid with histamine release.
Overall symptomatology is not the best way to narrow a possible etiology. Fever is not always present; although, this does not mean that there is no infection. The positive predictive value of dysentery is reduced as well. In the suspicion of acute gastroenteritis, appropriate laboratory testing is needed if the healthcare professional needs to verify the causative agent.
An evaluation with a proper clinical history is essential for every disease. Specific to a gastroenteritis episode is a history of contact, child-care attendance, travel, and exposure. Despite non-specific symptomatology, healthcare professionals can still narrow their options by correctly analyzing the symptoms. For example, nausea and vomiting indicate upper intestine; fever suggests inflammation (tissue invasion, dehydration or coinfection). Severe abdominal pain and tenesmus indicate large intestine involvement. The presence of nausea, vomiting with absent fever, periumbilical pain, and watery diarrhea suggest a non-serious small intestine infection.
Patients with diarrhea have the risk of dehydration; initial evaluation is to identify the presence and severity. Addressing the level of acidosis can provide valuable information to determine if fluid resuscitation is needed and if it should be oral or intravenous.
Microscopic stool examination and culture can narrow the causative agent. Mucus, blood or leukocytes may indicate the agent. The problem with this technique is that there can be false negatives at the early stage of the disease. Therefore, an XTAG GPP panel that is FDA approved uses multiplex nucleic acid technology that can detect C. difficile, toxin A/B, Campylobacter, Escherichia coli, Shigella and Shiga-like toxins, Salmonella, Rotavirus, Norovirus, Giardia, and Cryptosporidium.
Cultures should be done as promptly as possible in children that present leukocytes in the microscopic evaluation and have bloody diarrhea. Also, patients that are immunosuppressed should get a culture. This now is done with (PCR).
Overall, treatment and management of children with acute gastroenteritis involve rehydration (oral or IV), diet selection, zinc supplementation, and additional therapies like probiotics.
IV rehydration is needed in babies under 6 months, patients with chronic illness, prematurity, fever above 38 C (100.4 F) if younger than 3 months, or between 3 months and 36 months if the patient has more than 39 C (102.2 F). Persistent emesis, bloody diarrhea, altered mental status (consciousness) sunken eyes, and decrease urine output are also red flags that may lead the clinician to consider giving the patient IV fluids.
The treatment of choice is a low-osmolarity fluid, with 75 mEq of Na, 64 mEq of Cl, 20 mEq of K and 75 mmol of glucose per liter, the total osmolarity should be 245 mOsm/L. In mild to moderate emesis, give ondansetron (4 mg for children 4 to 11 years, and double the doses for older children) is often considered for better oral rehydration. IV rehydration is done with a lactated ringer or normal saline in 20 mL/Kg body weight.
Antibiotics are considered in certain situations. They may result in the reduction of severity and duration, even the prevention of some complications like the spread infection. Among the most used antibiotics are ciprofloxacin, TMP-SMX, erythromycin, and metronidazole. However, antibiotics should be avoided when the following causative agents are known: Bacillus cereus, Clostridium, and some Salmonella species.
The use of probiotics has not yet been scientifically proven to assist in the recovery or the symptomatology; studies have been inconclusive. It is believed that when the illness is caused by C. difficile, antibiotics might prevent diarrhea, and in the case of rotavirus, antibiotics could cause a reduction in the diarrheal duration. Antispasmodic agents like loperamide are contraindicated in children presenting dysentery.
When diagnosing acute gastroenteritis there are several differential etiological agents to consider:
Proctitis can also be another differential diagnosis that can be caused by Gonococcus, herpes simplex, Chlamydia, and Syphilis for example.
Other syndromes to consider are necrotizing enterocolitis, chronic inflammatory processes like parasites, Crohn's, ischemic colitis, and allergic enteritis.
There are also noninfectious illnesses that can lead to GI infection: arsenic, cadmium, copper, mercury, pesticides, and zinc.
Prognosis and complications are directly related to access to care and treatment.
There are not many options when it comes to treatment in the active set of gastroenteritis, but there are some measurements that can help prevent this disease. In newborns, exclusive breastfeeding for the first 6 months prevents diarrheal episodes. There are also studies that show vitamin-A supplementation reduces mortality in a diarrheal episode up to 30%. Other more well-known measurements are the rotavirus vaccine and the ingestion of clean water and food.
|Prevalence and genetic diversity of norovirus genogroup II in children less than 5 years of age with acute gastroenteritis in Tehran, Iran., Farsi M,Roodbari F,Nejati B,Arashkia A,Jalilvand S,Nateghian A,Rahbarimanesh A,Marashi SM,Shoja Z,, Medical microbiology and immunology, 2018 Apr 4 [PubMed PMID: 29619604]|
|Equipment-free nucleic acid extraction and amplification on a simple paper disc for point-of-care diagnosis of rotavirus A., Ye X,Xu J,Lu L,Li X,Fang X,Kong J,, Analytica chimica acta, 2018 Aug 14 [PubMed PMID: 29605138]|
|Campylobacter concisus and Acute Gastroenteritis in Children: Lack of Association., Tilmanne A,Martiny D,Hallin M,Cornelius A,Wautier M,Quach C,Lepage P,Vandenberg O,, The Pediatric infectious disease journal, 2018 Mar 29 [PubMed PMID: 29601450]|
|Pediatric hospitalizations attributable to rotavirus gastroenteritis among Cambodian children: Seven years of active surveillance, 2010-2016., Angkeabos N,Rin E,Vichit O,Chea C,Tech N,Payne DC,Fox K,Heffelfinger JD,Grabovac V,Nyambat B,Diorditsa S,Samnang C,Hossain MS,, Vaccine, 2018 Mar 24 [PubMed PMID: 29588120]|
|Effect of breastfeeding on common pediatric infections: a 5-year prospective cohort study., Ardiç C,Yavuz E,, Archivos argentinos de pediatria, 2018 Apr 1 [PubMed PMID: 29557599]|
|The economic burden of rotavirus infection in South Korea from 2009 to 2012., Lee KS,Lee YR,Park SY,Oh IH,, PloS one, 2018 [PubMed PMID: 29554108]|
|Antibiotic treatment of acute gastroenteritis in children., Bruzzese E,Giannattasio A,Guarino A,, F1000Research, 2018 [PubMed PMID: 29511533]|
|Rotavirus is the leading cause of hospitalizations for severe acute gastroenteritis among Afghan children <5 years old., Anwari P,Safi N,Payne DC,Jennings MC,Rasikh S,Waciqi AS,Parwiz SM,, Vaccine, 2018 Mar 3 [PubMed PMID: 29510917]|
|Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth., Bines JE,At Thobari J,Satria CD,Handley A,Watts E,Cowley D,Nirwati H,Ackland J,Standish J,Justice F,Byars G,Lee KJ,Barnes GL,Bachtiar NS,Viska Icanervilia A,Boniface K,Bogdanovic-Sakran N,Pavlic D,Bishop RF,Kirkwood CD,Buttery JP,Soenarto Y,, The New England journal of medicine, 2018 Feb 22 [PubMed PMID: 29466164]|
|Is there any difference between the symptomatology and clinical findings of viral agents causing dehydration?, Biçer S,Çöl D,Küçük Ö,Erdağ GÇ,Giray T,Uğraş M,Vitrinel A,Kaspar Ç,, Minerva pediatrica, 2018 Apr [PubMed PMID: 29446580]|
|Mechanisms to Evade the Phagocyte Respiratory Burst Arose by Convergent Evolution in Typhoidal Salmonella Serovars., Hiyoshi H,Wangdi T,Lock G,Saechao C,Raffatellu M,Cobb BA,Bäumler AJ,, Cell reports, 2018 Feb 13 [PubMed PMID: 29444431]|
|Acute gastroenteritis: evidence-based management of pediatric patients [digest]., Brady K,Pade KH,, Pediatric emergency medicine practice, 2018 Feb 1 [PubMed PMID: 29388753]|
|Acute gastroenteritis: evidence-based management of pediatric patients., Brady K,, Pediatric emergency medicine practice, 2018 Feb [PubMed PMID: 29369591]|
|Challenges in developing mucosal vaccines and antibodies against infectious diarrhea in children., Tokuhara D,, Pediatrics international : official journal of the Japan Pediatric Society, 2018 Mar [PubMed PMID: 29290097]|